Patent directory · USPTO A61K / A61P
Patents matching “inhibitors”
2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11390646
Structure-based peptide inhibitors of α-synuclein aggregation
granted -
US 11384076
Synthesis, pharmacology and use of new and selective FMS-like tyrosine kinase 3 (FLT3) FLT3 inhibitors
granted -
US 11382955
Long-acting VEGF inhibitors for intraocular neovascularization
granted -
US 11384055
Glycolate oxidase inhibitors for the treatment of disease
granted -
US 11377444
Pyridopyrimidine compounds acting as mTORC 1/2 dual inhibitors
granted -
US 11377469
CD73 inhibitors
granted -
US 11376247
Tyrosine kinase inhibitors regenerate non-cancerous tissue after cancer therapy
granted -
US 11370786
GLS1 inhibitors for treating disease
granted -
US 11370774
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
granted -
US 11370769
TRPC5 inhibitors and methods of using same
granted -
US 11370798
Compounds useful as inhibitors of ATR kinase
granted -
US 11370803
Heteroaryl plasma kallikrein inhibitors
granted -
US 11365189
Heterocyclic inhibitors of tyrosine kinase
granted -
US 11364211
Methods for selecting phosphatase selective and non-selective phosphatase inhibitors
granted -
US 11365195
Atypical inhibitors of monoamine transporters; method of making; and use thereof
granted -
US 11364300
C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors
granted -
US 11358932
N-(1-hydroxy-3-(pyrrolidinyl)propan-2-yl)pyrrolidine-3-carboxamide derivatives as glucosylceramide synthase inhibitors
granted -
US 11359246
Treatment of obesity with G-protein coupled receptor 75 (GPR75) inhibitors
granted -
US 11358947
Substituted 2-acylamino-cycloalkylthiophene-3-carboxylic acid arylamides as inhibitors of calcium-activated chloride channel TMEM16A
granted -
US 11351161
Use of CDK9 inhibitors to reduce cartilage degradation
granted -
US 11352356
Inhibitors of plasma kallikrein and uses thereof
granted -
US 11352360
TGF-beta inhibitors
granted -
US 11344605
Therapeutic use of inhibitors of t cell activation or stimulation
granted -
US 11345702
PGDH inhibitors and methods of making and using
granted